Redcare Pharmacy stock adds customer milestone to growth case
Published on 11/06/2026 at 11:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCustomer scale supports growth outlook
- Redcare Pharmacy operates across seven European markets and offers more than 500,000 healthcare-related products.
- Customer loyalty remained strong, with a repeat-order rate above 90% in the third quarter.
- The company continues to focus on digital prescriptions and broader access to pharmaceutical care.
Redcare Pharmacy announced on Thursday, November 5, that more than 15 million people across Europe had become active customers. The milestone, announced by EQS and carried by Financial Times, covers people who placed at least one order during the previous twelve months.
Customer scale broadens the platform
The company operates in seven European markets: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. Redcare offers more than 500,000 healthcare-related products, including over-the-counter medicines, nutritional supplements, beauty products and prescription drugs.
Management highlighted a repeat-order rate above 90% in the third quarter of 2026. The figure points to recurring customer activity, although the company did not provide a new revenue or profit forecast with the milestone announcement. Redcare continues to promote digital prescription services in Germany, where customers can redeem electronic prescriptions through the Shop Apotheke app.
The milestone follows Redcare's strong third-quarter operating performance. In the quarter, group revenue rose 18% year over year to 847 million euros, while adjusted EBITDA increased 68% to 28.7 million euros. The company kept its upgraded full-year 2026 targets, including revenue growth of 16% to 18% and an adjusted EBITDA margin of 2.5% to 3.0%.
Stock trades below Thursday close
Redcare Pharmacy stock traded at 71.70 euros on Lang & Schwarz at 11:02 CET on Friday, November 6, 1.10 percent below the Xetra close of Thursday, November 5. Investors are weighing the company's expanding customer base against the valuation and the execution required to convert prescription growth into sustained profitability.
Investors can follow the real-time quote of Redcare Pharmacy stock for further trading updates.
Redcare Pharmacy at a glance
- Company: Redcare Pharmacy N.V.
- ISIN: NL0012044747
- Listing: Frankfurt Stock Exchange, Prime Standard
- Index: SDAX
- Lang & Schwarz quote: 71.70 euros, Friday, November 6, 2026, 11:02 CET
- Daily change: 1.10 percent below the Xetra close of Thursday, November 5
- Xetra close: 72.50 euros, Thursday, November 5, 2026
The Dutch market backdrop is tracked through the AEX market theme.
More news and analyses on Redcare Pharmacy stock cover customer trends, prescription growth and the company's path toward higher profitability.
